Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.424NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.424NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.61NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.264NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.264NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.581NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.581NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.330NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.330NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.6.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.6.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.443NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.443NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.595.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.595.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.205NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.205NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.177NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.177NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.301NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.301NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.308NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.308NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.210NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.210NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.325NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.325NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.590NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.590NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.116NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.116NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.496NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.496NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.438.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.438.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.49 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.49 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.507NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.507NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.315NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.315NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.516NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.516NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used